Recent advances in angioplasty devices and pharmacologic therapies have significantly enhanced acute outcomes for STEMI patients, emphasizing the importance of prompt diagnosis and reduced door-to-balloon times.
Reinforces timely STEMI reperfusion in practice; leaves open prospective validation of specific advances.
ST-segment elevation myocardial infarction (STEMI) represents the most urgent condition for patients with coronary artery disease. Prompt diagnosis and therapy, mainly with primary angioplasty using stents, are important in improving not only acute survival but also long-term prognosis. Recent advances in angioplasty devices, including manual aspiration catheters and drug-eluting stents, and pharmacologic therapy, such as potent antiplatelet and anticoagulant agents, have significantly enhanced the acute outcome for these patients. Continuing efforts to educate the public and to decrease the door-to-balloon time are essential to further improve the outcome for these high-risk patients. Future research to normalize the left ventricular function by autologous stem cell therapy may also contribute to the quality of life and longevity of the patients surviving STEMI.
No takes yet. Share an insight, caveat, or question.
Mun K. Hong (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: